The ChemBioNet was initiated by biologists and chemists from academia who realized the need for interdisciplinary open access platforms to support research projects for systematic usage of small molecules to explore biological systems. This initiative wants to provide chemists with bioprofiles for their unique synthetic molecules and biologists developing unique assay systems, with access to high throughput technologies to identify compounds useful for dosage dependent, temporally or locally controlled interference with biological functions. In summary a novel discipline termed Chemical Biology. Four partner institutes (Helmholtz Centre for Infection Research, the Max-Delbrück-Center for Molecular Medicine, the University of Oslo and the Leibniz-Institut für Molekulare Pharmakologie, FMP) co-financed a shared central compound collection for screening. ... [Information of the supplier]
